Calls
1
u/AssociateLate1116
Reddit r/pennystocks
Win Rate
0.0%
return
-57.4%
Ticker
Side
Mentions
First Call
Call Price
P&L
Thesis
Theme
Source
Long
Feb 10
$9.62
-57.4%
The author argues INTS is significantly undervalued at a $20 million market cap after positive Phase 1/2 data, with upcoming Phase 3 enrollment as a near-term catalyst. The novel injection uses FDA-approved drugs to create an abscopal effect and extend survival, supported by a received patent and multiple Phase 2 studies. The author believes the company should be worth over $200 million and will attract joint ventures or buyout interest once Phase 3 starts, while noting likely additional funding raises as a risk.
Pharma & Biotech
Showing 1 of 1 calls · sorted by mentions
Choose a mentions count to open ticker posts.
u/AssociateLate1116 has 1 trade ideas tracked on Buzzberg across 1 tickers since February 2026. Most covered: INTS.
Historical call returns are modeled from recorded ideas and stored prices, not actual brokerage portfolio returns. Check the evaluated call set and horizon; past results do not establish future prediction accuracy. Explore our data and methodology
